DK563886A - THERAPEUTIC COMPOSITION - Google Patents
THERAPEUTIC COMPOSITIONInfo
- Publication number
- DK563886A DK563886A DK563886A DK563886A DK563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A
- Authority
- DK
- Denmark
- Prior art keywords
- disturbances
- composition
- bleeding
- well
- patients suffering
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The patent describes a process for treating patients suffering from bleeding disturbances which are not due to coagulation factor defects or coagulation factor inhibitors, as well as a previously unknown composition for use in the treatment of bleeding disturbances. The process involves administering, to a patient, a composition which comprises an effective haemostatic quantity of factor VIIa and it is particularly effective when treating patients suffering from thrombocytopenia and von Willebrand's syndrome, as well as other blood platelet disturbances. A composition which is suitable for treating such bleeding disturbances comprises purified factor VIIa in a concentration of at least 25 μg/ml.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK563886A DK156699C (en) | 1985-11-26 | 1986-11-25 | APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK544685A DK544685D0 (en) | 1985-11-26 | 1985-11-26 | THERAPEUTIC COMPOSITION |
DK544685 | 1985-11-26 | ||
DK459286A DK459286D0 (en) | 1986-09-26 | 1986-09-26 | THERAPEUTIC COMPOSITION |
DK459286 | 1986-09-26 | ||
DK563886A DK156699C (en) | 1985-11-26 | 1986-11-25 | APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders |
DK563886 | 1986-11-25 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK563886D0 DK563886D0 (en) | 1986-11-25 |
DK563886A true DK563886A (en) | 1987-05-27 |
DK156699B DK156699B (en) | 1989-09-25 |
DK156699C DK156699C (en) | 1990-03-05 |
Family
ID=27222001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK563886A DK156699C (en) | 1985-11-26 | 1986-11-25 | APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders |
Country Status (1)
Country | Link |
---|---|
DK (1) | DK156699C (en) |
-
1986
- 1986-11-25 DK DK563886A patent/DK156699C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK156699B (en) | 1989-09-25 |
DK156699C (en) | 1990-03-05 |
DK563886D0 (en) | 1986-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE66374T1 (en) | PREPARATIONS AND METHODS FOR TREATMENT OF BLOOD DISORDERS. | |
ATE295176T1 (en) | METHOD TO SUPPORT DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISTIC SYNDROME | |
DK0913156T3 (en) | Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis | |
BG60253B1 (en) | HUMAN TISSUE PLASMINOGENIC ACTIVATOR | |
DE69132688D1 (en) | METHOD FOR TREATING AND PREVENTING TYPE-1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN | |
NZ210275A (en) | Modified hirudin and its antithrombin properties | |
DE1300150T1 (en) | Prostaglandin derivatives used to treat glaucoma or hypertension | |
DE69230112T2 (en) | ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE | |
DE69230046T2 (en) | 2-bromomelatonin for the treatment of sleep disorders | |
ATE88899T1 (en) | WOUND HEALING AND BONE REGENERATION. | |
EA199800690A1 (en) | SUBSTITUTED N - [(AMINOIMINOMETHYL) PHENYLALKYL] AZHGETHROCYLAMIDE OF SULPHONIC ACIDS | |
EP0376251A3 (en) | An anticoagulant substance obtained from urine | |
DE3685853D1 (en) | AGENTS FOR THE TREATMENT OF BONE DISEASES. | |
ES2160643T3 (en) | COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF. | |
KR950703004A (en) | INHIBITOR OF COLLAGEN-STIMULATED PLATELET AGGREGATION | |
NO913129L (en) | NEW TROMBOLYTIC AGENT. | |
ATE80039T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 2',3'-DIDEOXYCYTIDIN-2'-EN(2',3'-DIDEOXY-2',3'DIDEHYDROCYTIDIN) FOR THE TREATMENT OF PATIENTS INFECTED WITH RETROVIRUS. | |
DE69327314D1 (en) | Compositions containing lipoprotein associated coagulation inhibitor (LACI) for the manufacture of a medicament for the treatment of acute or chronic inflammation | |
ATE126061T1 (en) | USE OF LITHIUM FOR THE TREATMENT OR PROPHYLAXIS OF MOLLUSCUM CONTAGIUSUM. | |
JPS5932443B2 (en) | Thrombin blocking substance, method for producing the same, and pharmaceutical composition for thrombin blocking containing the substance | |
ATE430578T1 (en) | FACTOR VIII OR VON WILLEBRAND FACTOR FOR THE TREATMENT OF THROMBOPATHY-ASSOCIATED HEMORRHAGIC DISEASES | |
DK563886A (en) | THERAPEUTIC COMPOSITION | |
ATE44750T1 (en) | PROCESS FOR PREPARING AN ANTI-HEMOPHILIA FACTOR CONCENTRATE. | |
DE3650368D1 (en) | Use of Depogen to treat restricted blood circulation. | |
UA7180C2 (en) | DRUG FOR TREATMENT AND PREVENTION OF ATHEROGENIC DISLIPOPROTEINEMIA AND HYPERCOAGULATION SYNDROME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |